| Symbol | HRMY |
|---|---|
| Name | HARMONY BIOSCIENCES HOLDINGS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 630 W. GERMANTOWN PIKE,SUITE 215, PLYMOUTH MEETING, Pennsylvania, 19462, United States |
| Telephone | +1 484 539-9800 |
| Fax | — |
| — | |
| Website | https://www.harmonybiosciences.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001802665 |
| Description | Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The companys product WAKIX pitolisant is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy. Additional info from NASDAQ: |
📋 VALOR IV PHARMA HOLDINGS LLC (Director) plans to sell 701K shares of HARMONY BIOSCIENCES HOLDINGS, INC. (at $37.90 each, total $26.6M) Filed: Aug 07, 2026 | ID: 007827
Read moreHarmony Biosciences to Participate in Piper Sandler Virtual CNS Symposium
Read moreHarmony Biosciences Announces Record Q2 2026 Revenue and Shares Initial Clinical Data for Its Orexin-2 Agonist BP-205 Reinforcing Potential Best-in-Class Profile
Read moreNew Form SCHEDULE 13G - Harmony Biosciences Holdings, Inc. <b>Filed:</b> 2026-07-31 <b>AccNo:</b> 0002100121-26-000926 <b>Size:</b> 7 KB
Read moreHarmony Biosciences To Report Second Quarter 2026 Financial Results On August 4, 2026
Read more(30% Negative) HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) Reports Q3 2026 Financial Results
Read more📋 SANDIP KAPADIA (Ex-Officer) plans to sell 25K shares of HARMONY BIOSCIENCES HOLDINGS, INC. (at $36.96 each, total $924K) Filed: Jul 02, 2026 | ID: 006806
Read more📋 SANDIP KAPADIA (Ex-Officer) plans to sell 4K shares of HARMONY BIOSCIENCES HOLDINGS, INC. (at $35.02 each, total $154K) Filed: Jun 24, 2026 | ID: 006445
Read moreParagon Advances Registration-Ready CNS Asset Addressing Important Unmet Need and Closes Sale to Teva Pharmaceutical
Read moreHarmony Biosciences Announces Poster Presentations at 2026 SLEEP Annual Meeting
Read more